Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Wednesday, February 28, 2024 · 691,992,792 Articles · 3+ Million Readers

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against EHang Holdings Limited (EH)

/EIN News/ -- SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired EHang Holdings Limited (NASDAQ: EH) securities between January 20, 2022 and November 6, 2023. EHang describes itself as an “autonomous aerial vehicle technology company.”

For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is this Case About: EHang Holdings Limited (EH) Misled Investors Regarding its Business Prospects

According to the complaint, during the class period, defendants failed to disclose that (1) EHang has continued to state that it was partnering with United Therapeutics, DHL, and Vodafone, among others, even though a former EHang employee has noted that United Therapeutics, DHL, and Vodafone have abandoned their respective deals with EHang and (2) EHang omitted that other entities that had placed pre-orders for its aircraft, such as Prestige Aviation and Shenzhen Boling Holding Group, did not engage in regular business in the aviation sector and are otherwise almost certainly not in a financial position to be able to afford their orders.

Plaintiff alleges that on November 7, 2023, Hindenburg Research released a report entitled “EHang: Hollow Order Book And Fake Sales Make This China-Based eVTOL Company Last in Line For Takeoff” (the “Hindenburg Report”). The Hindenburg Report made a number of allegations regarding the Company’s business, operations, and prospects, and raised issues with EHang’s purported deals with entities called United Therapeutics, Prestige Aviation, AirX, Shenzhen Boling Holdings Group, and DHL Sinotrans, among other things. On this news, the price of EHang ADSs declined by $1.90 per ADS, or 12.70%, to close at $13.06 on November 7, 2023.

What Now: Similarly situated shareholders may be eligible to participate in the class action against EHang Holdings Limited. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. Plaintiffs must file their lead plaintiff papers by February 2, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.  

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against EHang Holdings Limited settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contact:
Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

https://www.facebook.com/RobbinsLLP/
https://www.linkedin.com/company/robbins-llp/


Primary Logo

Powered by EIN News
Distribution channels: Consumer Goods, Law ...


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release